The revenue stands at ₹3,303.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 0.03 per cent from ₹3,302.00 crore. This corresponds to a year-on-year *(YoY) growth of 17.59 per cent.
Operating Profit stands at ₹1,078.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 0.75 per cent from ₹1,070.00 crore. This corresponds to a year-on-year *(YoY) growth of 17.94 per cent.
PBDT stands at ₹1,020.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.51 per cent from ₹995.00 crore. This corresponds to a year-on-year *(YoY) growth of 14.61 per cent.
Profit Before Tax stands at ₹814.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.91 per cent from ₹791.00 crore. This corresponds to a year-on-year *(YoY) growth of 17.80 per cent.
Net Profit stands at ₹635.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.45 per cent from ₹591.00 crore. This represents a 26.24 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Torrent Pharma. | 0.77% | -1.10% | 8.50% | 14.98% | 21.54% | 49.18% |
| Sun Pharma.Inds. | 0.84% | -0.63% | 2.86% | -3.62% | 10.77% | 11.84% |
| Divi's Lab. | -0.15% | 0.08% | 5.75% | -1.04% | 4.36% | 15.96% |
| Cipla | 0.31% | 0.46% | 1.98% | -11.13% | -14.31% | -3.54% |
| Dr Reddy's Labs | 0.58% | -0.91% | 4.39% | 1.38% | 3.29% | 15.57% |
| Lupin | 0.45% | 0.84% | 5.33% | 10.50% | 19.19% | 18.42% |
Executive Chairman : Samir Mehta
Independent Director : Ameera Shah
Independent Director : Nayantara Bali
Managing Director : Aman Mehta
Independent Director : Manish Choksi
Company Sec. & Compli. Officer : Chintan Trivedi
Independent Director : Nikhil Khattau
Non Executive Director : Jindal Mehta